1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Effector Binding
        1.2.3 ELISA
        1.2.4 Kinetic Binding Assays
        1.2.5 ADCC & CDC Cell-Based Assays
    1.3 Market by Application
        1.3.1 Global Biosimilar Testing and Development Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 PK assay
        1.3.3 Tiered Immunogenicity testing
        1.3.4 NAb assays
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biosimilar Testing and Development Services Market Perspective (2017-2028)
    2.2 Biosimilar Testing and Development Services Growth Trends by Region
        2.2.1 Biosimilar Testing and Development Services Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biosimilar Testing and Development Services Historic Market Size by Region (2017-2022)
        2.2.3 Biosimilar Testing and Development Services Forecasted Market Size by Region (2023-2028)
    2.3 Biosimilar Testing and Development Services Market Dynamics
        2.3.1 Biosimilar Testing and Development Services Industry Trends
        2.3.2 Biosimilar Testing and Development Services Market Drivers
        2.3.3 Biosimilar Testing and Development Services Market Challenges
        2.3.4 Biosimilar Testing and Development Services Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biosimilar Testing and Development Services Players by Revenue
        3.1.1 Global Top Biosimilar Testing and Development Services Players by Revenue (2017-2022)
        3.1.2 Global Biosimilar Testing and Development Services Revenue Market Share by Players (2017-2022)
    3.2 Global Biosimilar Testing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biosimilar Testing and Development Services Revenue
    3.4 Global Biosimilar Testing and Development Services Market Concentration Ratio
        3.4.1 Global Biosimilar Testing and Development Services Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Testing and Development Services Revenue in 2021
    3.5 Biosimilar Testing and Development Services Key Players Head office and Area Served
    3.6 Key Players Biosimilar Testing and Development Services Product Solution and Service
    3.7 Date of Enter into Biosimilar Testing and Development Services Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Testing and Development Services Breakdown Data by Type
    4.1 Global Biosimilar Testing and Development Services Historic Market Size by Type (2017-2022)
    4.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2023-2028)
5 Biosimilar Testing and Development Services Breakdown Data by Application
    5.1 Global Biosimilar Testing and Development Services Historic Market Size by Application (2017-2022)
    5.2 Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biosimilar Testing and Development Services Market Size (2017-2028)
    6.2 North America Biosimilar Testing and Development Services Market Size by Type
        6.2.1 North America Biosimilar Testing and Development Services Market Size by Type (2017-2022)
        6.2.2 North America Biosimilar Testing and Development Services Market Size by Type (2023-2028)
        6.2.3 North America Biosimilar Testing and Development Services Market Share by Type (2017-2028)
    6.3 North America Biosimilar Testing and Development Services Market Size by Application
        6.3.1 North America Biosimilar Testing and Development Services Market Size by Application (2017-2022)
        6.3.2 North America Biosimilar Testing and Development Services Market Size by Application (2023-2028)
        6.3.3 North America Biosimilar Testing and Development Services Market Share by Application (2017-2028)
    6.4 North America Biosimilar Testing and Development Services Market Size by Country
        6.4.1 North America Biosimilar Testing and Development Services Market Size by Country (2017-2022)
        6.4.2 North America Biosimilar Testing and Development Services Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Biosimilar Testing and Development Services Market Size (2017-2028)
    7.2 Europe Biosimilar Testing and Development Services Market Size by Type
        7.2.1 Europe Biosimilar Testing and Development Services Market Size by Type (2017-2022)
        7.2.2 Europe Biosimilar Testing and Development Services Market Size by Type (2023-2028)
        7.2.3 Europe Biosimilar Testing and Development Services Market Share by Type (2017-2028)
    7.3 Europe Biosimilar Testing and Development Services Market Size by Application
        7.3.1 Europe Biosimilar Testing and Development Services Market Size by Application (2017-2022)
        7.3.2 Europe Biosimilar Testing and Development Services Market Size by Application (2023-2028)
        7.3.3 Europe Biosimilar Testing and Development Services Market Share by Application (2017-2028)
    7.4 Europe Biosimilar Testing and Development Services Market Size by Country
        7.4.1 Europe Biosimilar Testing and Development Services Market Size by Country (2017-2022)
        7.4.2 Europe Biosimilar Testing and Development Services Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biosimilar Testing and Development Services Market Size (2017-2028)
    8.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type
        8.2.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Biosimilar Testing and Development Services Market Share by Type (2017-2028)
    8.3 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application
        8.3.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Biosimilar Testing and Development Services Market Share by Application (2017-2028)
    8.4 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region
        8.4.1 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Biosimilar Testing and Development Services Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Biosimilar Testing and Development Services Market Size (2017-2028)
    9.2 Latin America Biosimilar Testing and Development Services Market Size by Type
        9.2.1 Latin America Biosimilar Testing and Development Services Market Size by Type (2017-2022)
        9.2.2 Latin America Biosimilar Testing and Development Services Market Size by Type (2023-2028)
        9.2.3 Latin America Biosimilar Testing and Development Services Market Share by Type (2017-2028)
    9.3 Latin America Biosimilar Testing and Development Services Market Size by Application
        9.3.1 Latin America Biosimilar Testing and Development Services Market Size by Application (2017-2022)
        9.3.2 Latin America Biosimilar Testing and Development Services Market Size by Application (2023-2028)
        9.3.3 Latin America Biosimilar Testing and Development Services Market Share by Application (2017-2028)
    9.4 Latin America Biosimilar Testing and Development Services Market Size by Country
        9.4.1 Latin America Biosimilar Testing and Development Services Market Size by Country (2017-2022)
        9.4.2 Latin America Biosimilar Testing and Development Services Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biosimilar Testing and Development Services Market Size (2017-2028)
    10.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type
        10.2.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Biosimilar Testing and Development Services Market Share by Type (2017-2028)
    10.3 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application
        10.3.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Biosimilar Testing and Development Services Market Share by Application (2017-2028)
    10.4 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country
        10.4.1 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Biosimilar Testing and Development Services Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Eurofins Scientific
        11.1.1 Eurofins Scientific Company Details
        11.1.2 Eurofins Scientific Business Overview
        11.1.3 Eurofins Scientific Biosimilar Testing and Development Services Introduction
        11.1.4 Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.1.5 Eurofins Scientific Recent Developments
    11.2 SGS
        11.2.1 SGS Company Details
        11.2.2 SGS Business Overview
        11.2.3 SGS Biosimilar Testing and Development Services Introduction
        11.2.4 SGS Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.2.5 SGS Recent Developments
    11.3 Charles River Laboratories
        11.3.1 Charles River Laboratories Company Details
        11.3.2 Charles River Laboratories Business Overview
        11.3.3 Charles River Laboratories Biosimilar Testing and Development Services Introduction
        11.3.4 Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.3.5 Charles River Laboratories Recent Developments
    11.4 Pharmaceutical Product Development
        11.4.1 Pharmaceutical Product Development Company Details
        11.4.2 Pharmaceutical Product Development Business Overview
        11.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Introduction
        11.4.4 Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.4.5 Pharmaceutical Product Development Recent Developments
    11.5 Exova
        11.5.1 Exova Company Details
        11.5.2 Exova Business Overview
        11.5.3 Exova Biosimilar Testing and Development Services Introduction
        11.5.4 Exova Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.5.5 Exova Recent Developments
    11.6 Source BioScience
        11.6.1 Source BioScience Company Details
        11.6.2 Source BioScience Business Overview
        11.6.3 Source BioScience Biosimilar Testing and Development Services Introduction
        11.6.4 Source BioScience Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.6.5 Source BioScience Recent Developments
    11.7 Intertek Group
        11.7.1 Intertek Group Company Details
        11.7.2 Intertek Group Business Overview
        11.7.3 Intertek Group Biosimilar Testing and Development Services Introduction
        11.7.4 Intertek Group Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.7.5 Intertek Group Recent Developments
    11.8 Medistri
        11.8.1 Medistri Company Details
        11.8.2 Medistri Business Overview
        11.8.3 Medistri Biosimilar Testing and Development Services Introduction
        11.8.4 Medistri Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.8.5 Medistri Recent Developments
    11.9 Pace Analytical Services
        11.9.1 Pace Analytical Services Company Details
        11.9.2 Pace Analytical Services Business Overview
        11.9.3 Pace Analytical Services Biosimilar Testing and Development Services Introduction
        11.9.4 Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.9.5 Pace Analytical Services Recent Developments
    11.10 Sigma-Aldrich
        11.10.1 Sigma-Aldrich Company Details
        11.10.2 Sigma-Aldrich Business Overview
        11.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Introduction
        11.10.4 Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2017-2022)
        11.10.5 Sigma-Aldrich Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Biosimilar Testing and Development Services Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Effector Binding
    Table 3. Key Players of ELISA
    Table 4. Key Players of Kinetic Binding Assays
    Table 5. Key Players of ADCC & CDC Cell-Based Assays
    Table 6. Global Biosimilar Testing and Development Services Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Biosimilar Testing and Development Services Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Biosimilar Testing and Development Services Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Biosimilar Testing and Development Services Market Share by Region (2017-2022)
    Table 10. Global Biosimilar Testing and Development Services Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Biosimilar Testing and Development Services Market Share by Region (2023-2028)
    Table 12. Biosimilar Testing and Development Services Market Trends
    Table 13. Biosimilar Testing and Development Services Market Drivers
    Table 14. Biosimilar Testing and Development Services Market Challenges
    Table 15. Biosimilar Testing and Development Services Market Restraints
    Table 16. Global Biosimilar Testing and Development Services Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Biosimilar Testing and Development Services Revenue Share by Players (2017-2022)
    Table 18. Global Top Biosimilar Testing and Development Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2021)
    Table 19. Ranking of Global Top Biosimilar Testing and Development Services Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Biosimilar Testing and Development Services Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Biosimilar Testing and Development Services Product Solution and Service
    Table 23. Date of Enter into Biosimilar Testing and Development Services Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2017-2022)
    Table 27. Global Biosimilar Testing and Development Services Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Biosimilar Testing and Development Services Revenue Market Share by Type (2023-2028)
    Table 29. Global Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Biosimilar Testing and Development Services Revenue Share by Application (2017-2022)
    Table 31. Global Biosimilar Testing and Development Services Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Biosimilar Testing and Development Services Revenue Share by Application (2023-2028)
    Table 33. North America Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Biosimilar Testing and Development Services Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Biosimilar Testing and Development Services Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Biosimilar Testing and Development Services Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Biosimilar Testing and Development Services Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Biosimilar Testing and Development Services Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Biosimilar Testing and Development Services Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Biosimilar Testing and Development Services Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Biosimilar Testing and Development Services Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Eurofins Scientific Company Details
    Table 64. Eurofins Scientific Business Overview
    Table 65. Eurofins Scientific Biosimilar Testing and Development Services Product
    Table 66. Eurofins Scientific Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 67. Eurofins Scientific Recent Developments
    Table 68. SGS Company Details
    Table 69. SGS Business Overview
    Table 70. SGS Biosimilar Testing and Development Services Product
    Table 71. SGS Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 72. SGS Recent Developments
    Table 73. Charles River Laboratories Company Details
    Table 74. Charles River Laboratories Business Overview
    Table 75. Charles River Laboratories Biosimilar Testing and Development Services Product
    Table 76. Charles River Laboratories Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 77. Charles River Laboratories Recent Developments
    Table 78. Pharmaceutical Product Development Company Details
    Table 79. Pharmaceutical Product Development Business Overview
    Table 80. Pharmaceutical Product Development Biosimilar Testing and Development Services Product
    Table 81. Pharmaceutical Product Development Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 82. Pharmaceutical Product Development Recent Developments
    Table 83. Exova Company Details
    Table 84. Exova Business Overview
    Table 85. Exova Biosimilar Testing and Development Services Product
    Table 86. Exova Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 87. Exova Recent Developments
    Table 88. Source BioScience Company Details
    Table 89. Source BioScience Business Overview
    Table 90. Source BioScience Biosimilar Testing and Development Services Product
    Table 91. Source BioScience Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 92. Source BioScience Recent Developments
    Table 93. Intertek Group Company Details
    Table 94. Intertek Group Business Overview
    Table 95. Intertek Group Biosimilar Testing and Development Services Product
    Table 96. Intertek Group Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 97. Intertek Group Recent Developments
    Table 98. Medistri Company Details
    Table 99. Medistri Business Overview
    Table 100. Medistri Biosimilar Testing and Development Services Product
    Table 101. Medistri Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 102. Medistri Recent Developments
    Table 103. Pace Analytical Services Company Details
    Table 104. Pace Analytical Services Business Overview
    Table 105. Pace Analytical Services Biosimilar Testing and Development Services Product
    Table 106. Pace Analytical Services Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 107. Pace Analytical Services Recent Developments
    Table 108. Sigma-Aldrich Company Details
    Table 109. Sigma-Aldrich Business Overview
    Table 110. Sigma-Aldrich Biosimilar Testing and Development Services Product
    Table 111. Sigma-Aldrich Revenue in Biosimilar Testing and Development Services Business (2017-2022) & (US$ Million)
    Table 112. Sigma-Aldrich Recent Developments
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biosimilar Testing and Development Services Market Share by Type: 2021 VS 2028
    Figure 2. Effector Binding Features
    Figure 3. ELISA Features
    Figure 4. Kinetic Binding Assays Features
    Figure 5. ADCC & CDC Cell-Based Assays Features
    Figure 6. Global Biosimilar Testing and Development Services Market Share by Application: 2021 VS 2028
    Figure 7. PK assay Case Studies
    Figure 8. Tiered Immunogenicity testing Case Studies
    Figure 9. NAb assays Case Studies
    Figure 10. Biosimilar Testing and Development Services Report Years Considered
    Figure 11. Global Biosimilar Testing and Development Services Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Biosimilar Testing and Development Services Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Biosimilar Testing and Development Services Market Share by Region: 2021 VS 2028
    Figure 14. Global Biosimilar Testing and Development Services Market Share by Players in 2021
    Figure 15. Global Top Biosimilar Testing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Testing and Development Services as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2021
    Figure 17. North America Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
    Figure 19. North America Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
    Figure 20. North America Biosimilar Testing and Development Services Market Size Share by Country (2017-2028)
    Figure 21. United States Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Biosimilar Testing and Development Services Market Size Share by Country (2017-2028)
    Figure 27. Germany Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Biosimilar Testing and Development Services Market Size Share by Region (2017-2028)
    Figure 37. China Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Biosimilar Testing and Development Services Market Size Share by Country (2017-2028)
    Figure 47. Mexico Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Biosimilar Testing and Development Services Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Biosimilar Testing and Development Services Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Biosimilar Testing and Development Services Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Biosimilar Testing and Development Services Market Size Share by Country (2017-2028)
    Figure 53. Turkey Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Biosimilar Testing and Development Services Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Eurofins Scientific Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 57. SGS Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 58. Charles River Laboratories Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 59. Pharmaceutical Product Development Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 60. Exova Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 61. Source BioScience Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 62. Intertek Group Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 63. Medistri Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 64. Pace Analytical Services Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 65. Sigma-Aldrich Revenue Growth Rate in Biosimilar Testing and Development Services Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed